Cargando…

MYCN contributes to the malignant characteristics of erythroleukemia through EZH2-mediated epigenetic repression of p21

MYC proto-oncogene family including c-myc and n-myc (MYCN) are critical for normal cell development and tumorigenesis. Overexpression of c-myc causes acute erythroleukemia in vivo. However, the role of MYCN in acute erythroleukemia remains poorly understood. In this study, we found that the patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Li, Xu, Feng, Chang, Chun-Kang, He, Qi, Wu, Ling-Yun, Zhang, Zheng, Li, Xiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5682688/ https://www.ncbi.nlm.nih.gov/pubmed/29022893 http://dx.doi.org/10.1038/cddis.2017.526

Ejemplares similares

Erythroleukemia: Classification
por: Cervera, Nathalie, et al.
Publicado: (2023)

Differentiation of murine erythroleukemia cells results in the rapid repression of vimentin gene expression
Publicado: (1984)

Epigenetic repression of the Igk locus by STAT5-mediated Ezh2 recruitment
por: Mandal, Malay, et al.
Publicado: (2011)

EZH2 regulates neuroepithelium structure and neuroblast proliferation by repressing p21
por: Akizu, Naiara, et al.
Publicado: (2016)

EZH2 promotes metabolic reprogramming in glioblastomas through epigenetic repression of EAF2-HIF1α signaling
por: Pang, Bo, et al.
Publicado: (2016)

Epigenetic repression of cardiac progenitor gene expression by Ezh2 is required for postnatal cardiac homeostasis
por: Delgado-Olguín, Paul, et al.
Publicado: (2012)

MYCN-mediated transcriptional repression in neuroblastoma: the other side of the coin
por: Gherardi, Samuele, et al.
Publicado: (2013)

MYCN repression of Lifeguard/FAIM2 enhances neuroblastoma aggressiveness
por: Planells-Ferrer, L, et al.
Publicado: (2014)

Inhibitors of ribosome biogenesis repress the growth of MYCN-amplified neuroblastoma
por: Hald, Øyvind H., et al.
Publicado: (2018)

EZH2-mediated epigenetic repression of DNA repair in promoting breast tumor initiating cells
por: Stefansson, Olafur Andri, et al.
Publicado: (2011)

Polycomb EZH1 regulates cell cycle/5‐fluorouracil sensitivity of neuroblastoma cells in concert with MYCN
por: Shinno, Yoshitaka, et al.
Publicado: (2022)

Molecular Landscapes and Models of Acute Erythroleukemia
por: Fagnan, Alexandre, et al.
Publicado: (2021)

Erythroleukemia cells acquire an alternative mitophagy capability
por: Wang, Jian, et al.
Publicado: (2016)

PRMT5 functionally associates with EZH2 to promote colorectal cancer progression through epigenetically repressing CDKN2B expression
por: Yang, Liu, et al.
Publicado: (2021)

Genomic loss of EZH2 leads to epigenetic modifications and overexpression of the HOX gene clusters in myelodysplastic syndrome
por: Xu, Feng, et al.
Publicado: (2016)

MYCN and HDAC2 cooperate to repress miR-183 signaling in neuroblastoma
por: Lodrini, Marco, et al.
Publicado: (2013)

MYCN transcriptionally represses CD9 to trigger an invasion-metastasis cascade in neuroblastoma
por: Fabian, Johannes, et al.
Publicado: (2015)

Functional Evaluation of KEL as an Oncogenic Gene in the Progression of Acute Erythroleukemia
por: Liu, Wenjie, et al.
Publicado: (2022)

Epigenetic regulation of the neuroblastoma genes, Arid3b and Mycn
por: Kobayashi, K, et al.
Publicado: (2013)

HIF1α epigenetically repressed macrophages via CRISPR/Cas9-EZH2 system for enhanced cancer immunotherapy
por: Dong, Yan, et al.
Publicado: (2021)

Aberrant MYCN expression drives oncogenic hijacking of EZH2 as a transcriptional activator in peripheral T-cell lymphoma
por: Vanden Bempt, Marlies, et al.
Publicado: (2022)

EZH1 and EZH2 promote skeletal growth by repressing inhibitors of chondrocyte proliferation and hypertrophy
por: Lui, Julian C., et al.
Publicado: (2016)

Inhibition of EZH2 primes the cardiac gene activation via removal of epigenetic repression during human direct cardiac reprogramming
por: Tang, Yawen, et al.
Publicado: (2021)

Targeting epigenetics in sarcomas through EZH2 inhibition
por: Italiano, Antoine
Publicado: (2020)

Repressing the repressor: Ezh2 mediates macrophage activation
por: Neele, Annette E., et al.
Publicado: (2018)

Targeting MYCN in Molecularly Defined Malignant Brain Tumors
por: Borgenvik, Anna, et al.
Publicado: (2021)

Lnc-PDZD7 contributes to stemness properties and chemosensitivity in hepatocellular carcinoma through EZH2-mediated ATOH8 transcriptional repression
por: Zhang, Yi, et al.
Publicado: (2019)

MYCN and HDAC5 transcriptionally repress CD9 to trigger invasion and metastasis in neuroblastoma
por: Fabian, Johannes, et al.
Publicado: (2016)

EZH2-Mediated H3K27me3 Is Involved in Epigenetic Repression of Deleted in Liver Cancer 1 in Human Cancers
por: Au, Sandy Leung-Kuen, et al.
Publicado: (2013)

EZH2 contributes to 5-FU resistance in gastric cancer by epigenetically suppressing FBXO32 expression
por: Wang, Chenyu, et al.
Publicado: (2018)

EZH2 in Myeloid Malignancies
por: Rinke, Jenny, et al.
Publicado: (2020)

Hypomethylation of DNA during differentiation of friend erythroleukemia cells
por: Christman, JK, et al.
Publicado: (1980)

c-myc protooncogene expression in mouse erythroleukemia cells.
por: Lachman, H M
Publicado: (1989)

Erythroleukemia Relapsing as Precursor B-cell Lymphoblastic Leukemia
por: Park, Borae G., et al.
Publicado: (2011)

Chronic lymphocytic leukemia followed by myelodysplastic syndrome and erythroleukemia
por: Cazaceanu, O, et al.
Publicado: (2012)

PROTAC Bromodomain Inhibitor ARV-825 Displays Anti-Tumor Activity in Neuroblastoma by Repressing Expression of MYCN or c-Myc
por: Li, Zhiheng, et al.
Publicado: (2020)

MYCN Amplification Is Associated with Repressed Cellular Immunity in Neuroblastoma: An In Silico Immunological Analysis of TARGET Database
por: Zhang, Peng, et al.
Publicado: (2017)

MYCN and PRC1 cooperatively repress docosahexaenoic acid synthesis in neuroblastoma via ELOVL2
por: Ding, Yi, et al.
Publicado: (2019)

P1297: ABERRANT MYCN EXPRESSION DRIVES ONCOGENIC HIJACKING OF EZH2 AS A TRANSCRIPTIONAL ACTIVATOR IN PERIPHERAL T CELL LYMPHOMA
por: Vanden Bempt, M., et al.
Publicado: (2022)

Epigenetic repression of Krüppel-like factor 4 through Dnmt1 contributes to EMT in renal fibrosis
por: XIAO, XIANGCHENG, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_tu0tbcd63ef9tn4a1ga15mr7nr